Docetaxel versus abiraterone acetate for metastatic hormone-sensitive prostate cancer: a real-life analysis

Autor:	Silvia Foti, Igor Tsaur, Anita Thomas, P. Ermacora, Guillaume Ploussard, Mona Kafka, Constance Thibault, Jarmo C B Hunting, Jasmin Bektic, Robert Dotzauer, G. Von Amsberg, Isabel Heidegger, Thomas Höfner, Maximilian P Brandt, F. Zattoni, Barak Rosenzweig, R.C.N. Van Den Bergh, Severin Rodler, Moran Gadot, E. Debedde, Derya Tilki, G. Gandaglia, Cristian Surcel, A. Kretschmer
Rok vydání:	2021
Předmět:	Oncology medicine.medical_specialty chemistry.chemical_compound Hormone sensitive prostate cancer Docetaxel chemistry business.industry Urology Internal medicine medicine Abiraterone acetate business medicine.drug
Zdroj:	European Urology Open Science. 33:S283-S284
ISSN:	2666-1683
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::0d48654a1512f8a59f6431311cb46d6c https://doi.org/10.1016/s2666-1683(21)03138-4 Zobrazit plný text záznamu